Patient-Reported Outcomes Following the Use of Jiang Tang San Huang Tablets in Type 2 Diabetes Mellitus: A Retrospective Cohort Study in a Chinese Population

References

• Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. doi:10.1016/j.diabres.2021.109119
   PubMed Web of Science ®Google Scholar
• Heller SR, Peyrot M, Oates SK, et al. Hypoglycemia in patient with type 2 diabetes treated with insulin: it can happen. BMJ Open Diabetes Res Care. 2020;8(1):e001194. doi:10.1136/bmjdrc-2020-001194
   PubMed Web of Science ®Google Scholar
• Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy. 2012;32(7):613–617. doi:10.1002/j.1875-9114.2011.01088.x
   PubMed Web of Science ®Google Scholar
• Kong M, Xie K, Lv M, et al. Anti-inflammatory phytochemicals for the treatment of diabetes and its complications: lessons learned and future promise. Biomed Pharmacother. 2021;133:110975. doi:10.1016/j.biopha.2020.110975
   PubMed Web of Science ®Google Scholar
• Liu M, Liu Z, Xu B, Zhang W, Cai J. Review of systematic reviews and meta-analyses investigating Traditional Chinese medicine treatment for type 2 diabetes mellitus. J Tradit Chin Med. 2016;36(5):555–563. doi:10.1016/s0254-6272(16)30074-7
   PubMed Web of Science ®Google Scholar
• Tian J, Lian F, Yu X, et al. The efficacy and safety of Chinese herbal decoction in type 2 diabetes: a 5-year retrospective study. Evid Based Complement Alternat Med. 2016;2016:5473015. doi:10.1155/2016/5473015
   Web of Science ®Google Scholar
• Chen H, Guo J, Zhao X, et al. Retrospective analysis of the overt proteinuria diabetic kidney disease in the treatment of modified Shenzhuo formula for 2 years. Medicine. 2017;96(12):e6349. doi:10.1097/MD.0000000000006349
   Web of Science ®Google Scholar
• Jin D, Tian J, Bao Q, et al. Does adjuvant treatment with Chinese herbal medicine to anti-diabetic agents have additional benefits in patients with type 2 diabetes? A system review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med. 2019;2019:1825750. doi:10.1155/2019/1825750
   Web of Science ®Google Scholar
• Tian J, Zhao L, Zhou Q, et al. Efficacy of Shenzhuo formula on diabetic kidney disease: a retrospective study. J Tradit Chin Med. 2015;35(5):528–536. doi:10.1016/s0254-6272(15)30135-7
   Web of Science ®Google Scholar
• Pang B, Lian FM, Zhao XY, et al. Prevention of type 2 diabetes with the traditional Chinese patent medicine: a systematic review and meta-analysis. Diabetes Res Clin Pract. 2017;131:242–259. doi:10.1016/j.diabres.2017.07.020
   Web of Science ®Google Scholar
• Tian J, Lian F, Yu X, et al. Corrigendum to “the efficacy and safety of Chinese herbal decoction in type 2 diabetes: a 5-year retrospective study”. Evid Based Complement Alternat Med. 2017;2017:7683754. doi:10.1155/2017/7683754
   Web of Science ®Google Scholar
• Pang B, Zhou Q, Zhao TY, et al. Innovative thoughts on treating diabetes from the perspective of traditional Chinese medicine. Evid Based Complement Alternat Med. 2015;2015:905432. doi:10.1155/2015/905432
   Web of Science ®Google Scholar
• Pumthong G, Nathason A, Tuseewan M, et al. Complementary and alternative medicines for diabetes mellitus management in ASEAN countries. Complement Ther Med. 2015;23(4):617–625. doi:10.1016/j.ctim.2015.01.016
   Web of Science ®Google Scholar
• Lian F, Ni Q, Shen Y, et al. International traditional Chinese medicine guideline for diagnostic and treatment principles of diabetes. Ann Palliat Med. 2020;9(4):2237–2250. doi:10.21037/apm-19-271
   Web of Science ®Google Scholar
• Jianping L. Evaluation mode of clinical efficacy of traditional Chinese medicine combining quantitative and qualitative research methods. Chin J Integr Med. 2011;31(5):581–586.
   Google Scholar
• Zhang S, Lu H. Development and entry screening of pro scale for evaluating therapeutic effect of traditional Chinese medicine on diabetes mellitus. China J Trad Chin Med Pharm. 2018;33(2):598–602.
   Google Scholar
• Chen YT, Tan YZ, Cheen M, Wee HL. Patient-reported outcome measures in registry-based studies of type 2 diabetes mellitus: a systematic review. Curr Diab Rep. 2019;19(11):135. doi:10.1007/s11892-019-1265-8
   Web of Science ®Google Scholar
• Roborel de Climens A, Tunceli K, Arnould B, et al. Review of patient-reported outcome instruments measuring health-related quality of life and satisfaction in patients with type 2 diabetes treated with oral therapy. Curr Med Res Opin. 2015;31(4):643–665. doi:10.1185/03007995.2015.1020364
   PubMed Web of Science ®Google Scholar
• Ishii H, Nakajima H, Kamei N, et al. Comparison of patient-led and physician-led insulin titration in Japanese type 2 diabetes mellitus patients based on treatment distress, satisfaction, and self-efficacy: the COMMIT-patient study. Diabetes Ther. 2021;12(2):595–611. doi:10.1007/s13300-020-00995-8
   Web of Science ®Google Scholar
• Basch E, Deal AM, Dueck AC, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA. 2017;318(2):197–198. doi:10.1001/jama.2017.7156
   PubMed Web of Science ®Google Scholar
• Bouazza YB, Chiairi I, El Kharbouchi O, et al. Patient-reported outcome measures (PROMs) in the management of lung cancer: a systematic review. Lung Cancer. 2017;113:140–151. doi:10.1016/j.lungcan.2017.09.011
   PubMed Web of Science ®Google Scholar
• Hillebrand LE, Soling U, Marschner N. Significance of patient-reported outcomes for metastatic breast cancer patients. Oncol Res Treat. 2022;45(7–8):423–429. doi:10.1159/000521826
   Web of Science ®Google Scholar
• Yap NY, Loo WS, Zheng HF, et al. A study protocol for health-related quality of life-intervention in survivors of breast and other cancers experiencing cancer-related fatigue using traditional Chinese medicine: the HERBAL trial. Trials. 2020;21(1):909. doi:10.1186/s13063-020-04810-4
   PubMed Web of Science ®Google Scholar
• Liu S, Lai J, Wu L, et al. Chinese medicine for chronic obstructive pulmonary disease: a pilot study on patient preferences. Patient Prefer Adherence. 2021;15:1529–1535. doi:10.2147/PPA.S316872
   PubMed Web of Science ®Google Scholar
• Bensoussan A, Talley NJ, Hing M, et al. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA. 1998;280(18):1585–1589. doi:10.1001/jama.280.18.1585
   PubMed Web of Science ®Google Scholar
• Manqi X, Liuwen L, Anzhong L, et al. Clinical and experimental study of Jiangtang Sanhuang tablet in the treatment of type 2 diabetes mellitus. Chin J Integr Med. 1992;12(2):74–76.
   Google Scholar
• Cao ZB, Wang BH, Xu SJ, et al. Discussion on network of ‘insulin resistance-pancreatic beta cell defect-hyperglycemiaT2DM’ based on ‘fire-heat theory. J Tradit Chin Med. 2019;34(8):3668–3671.
   Google Scholar
• World Medical Association. Declaration of Helsinki ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191–2194. doi:10.1001/jama.2013.281053
   PubMed Web of Science ®Google Scholar
• Horakova D, Stepanek L, Stepanek L, et al. What are the real associations of homeostasis model assessment (HOMA) with body mass index and age? Endokrynol Pol. 2022;73(4):736–742. doi:10.5603/EP.a2022.0031
   Web of Science ®Google Scholar
• Xiaoyu Z. Guiding Principles for Clinical Research of New Traditional Chinese Medicine. Beijing: China Pharmaceutical Science and Technology Press; 2002:67–68.
   Google Scholar
• Fang J, Lin S, Wan GB. Effect of Jiangtang Sanhuang pill in the treatment of metabolic syndrome. J Tradit Chin Med. 2010;51(7):607–610.
   Google Scholar
• Wang B, Liu Y, Bai J, et al. Acute and long-term toxicity of Jiangtang Sanhuang tablet. Acta Chin Med Pharmacol. 2021;49(8):27–31.
   Google Scholar
• Kaiyan H, Meiqi Z. Experiment study of Jiangtang Sanhuang tablets on improving inflammatory responses in pancreatic β cells of mice with type 2 diabetes mellitus. J Chin Med. 2021;53(24):1–5. doi:10.13457/j.cnki.jncm.2021.24.001
   Google Scholar
• Qiang X, Hong-yu H, Mei-si Z, et al. Mechanism of modified Taohe Chengqitang in treating diabetic nephropathy based on network pharmacology. Chin J Experimet Trad Med Formulae. 2019;25(23). doi:10.13422/j.cnki.syfjx.20192141
   Google Scholar